Our Most-Read Member Stories of the Year
Our members are a vibrant community of risk-takers, visionaries and collaborators who are advancing science to improve lives and making significant contributions that build a better world. We regularly highlight our members’ latest innovations, breakthroughs and successes. In case you missed them, here are our top five stories from 2024.
5. Yatiri Bio Leverages Proteomics, Bioinformatics and Precision Medicine to Transform Cancer Drug Discovery: We spoke with Pilgrim Jackson, CEO of Yatiri Bio, on the
resurgence of proteomics in biotech and how the company is revolutionizing cancer drug discovery by tackling its current inefficiencies.
4. Arialys Therapeutics is Pioneering Breakthroughs in Auto-Immune Neurology and Treating Rare CNS Disorders: “The brain is one of the last frontiers, like the ocean or outer space. There’s a lot that we still don’t understand about it,” says Mathew B. Mitchell, senior vice president of corporate development at Arialys, in this
Q&A about the company’s breakthroughs.
3. Synbio: Revolutionizing Green API Manufacturing: This
contributed article by Ginkgo Bioworks delves into how synthetic biology can be a transformative solution toward manufacturing Active Pharmaceutical Ingredients sustainably.
2. Shionogi’s New Expanded Discovery Lab in San Diego Will Strengthen International Collaborations to Fight Antimicrobial Resistance Worldwide: Shionogi, a Japanese pharma company, acquired Qpex Biopharma to
advance antimicrobial resistance research and will open its first U.S. discovery lab in San Diego in 2025.
1. Q&A With Acclaimed Physician and Researcher Dr. Paul R. Billings, CEO of Biological Dynamics: A deep dive into the company’s
exosome isolation technology and why it may be the key in early disease detection.
